Baixar PDF
Artigo anterior
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
EXPERIENCES WITH CLOTTING FACTOR PROPHYLAXIS AND EXPECTATIONS TOWARD EMERGING THERAPIES IN HEMOPHILIA CARE IN BRAZIL: A QUALITATIVE INTERVIEW STUDY
JB Balardin; GG Yamaguti-Hayakawa; CF Carvalho; VdS da Silva; TMO Pietrobelli; MR Alves; AD Dantas; DVPV Pachito;
Hematol Transfus Cell Ther. 2025;47 Supl 3:
WHAT ARE THE PERCEPTIONS AND MOST RELEVANT TREATMENT OUTCOMES REGARDING GENE THERAPY ACCORDING TO PEOPLE WITH HEMOPHILIAS IN BRAZIL? STUDY PROTOCOL FOR A QUALITATIVE PATIENT PREFERENCE STUDY
F Vicente; J Balardin; L Piton; R Feitoza; S Lima; DV Pachito;
Hematol Transfus Cell Ther. 2023;45 Supl 4:S462-3
SOCIAL RETURN OF INVESTMENT ANALYSIS OF GENE THERAPY FOR HEMOPHILIA IN BRAZIL: STUDY PROTOCOL
DV Pachito; J Balardin; L Piton; R Feitoza; PHRF Almeida; S Lima; F Vicente;
Hematol Transfus Cell Ther. 2023;45 Supl 4:S462